Phase 3 Readout~month

Phase 3 Topline: A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) an

Indication
Brain Stem Glioma

Other upcoming events for BZYR

Phase 3 ReadoutPhase 3 Topline: A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugen

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar